Can they get there?, page-58

Gloriana whichever global medical device company offers us the best deal at auction will provide more expertise and sales than a little company like Analytica could even dream about and will have first class channels in place already.
As long as Pericoach is effective enough, which brings me to my concern and confusion regarding V2 and the clinical trial. No explanation for delay; not knowing what Monsour meant by 'we have a real dilemma' with the clinical trial; V3 apparently is still being assessed yet apparently already in production; was V3 necessary because V2 wasn't effective enough?
On the other hand V2 is being recommended by clinicians. The company claims it is effective and is best in class. It has required clearances including OTC.
V3 adds technical ability. Plans for only a 12 week trial suggests to me it is only to confirm what they already know.
Peter Corr became inolved after the trial had commenced and after doing due diligence on the product, on Dr Monsour, and on Analytica. If not confident he would not risk his great reputation or INOV8's capital. And the Dr invested another million after the trial started.
In a way I hope the Co does need cash, to see if INOV8 increases their stake - a good signal either way.
I also wonder how effective the product has to be for the big multi's to be interested - is minimal effectiveness good enough given the huge market? Too many questions still. Atleast we don't have to wait long now for V2 results/indications.
The current sp gives folk an opportunity for riches. Obviously people know there's no hurry, so why pay .06 when you might get a 20% discount. I expect a rise late Feb/early Mar though.
I really should learn to write short posts. Have a good weekend all.